PubMed

Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial.

van Venrooij FV, van de Ree MA, Bots ML, Stolk RP, Huisman MV, Banga JD; DALI Study Group.

Diabetes Care. 2002 Jul;25(7):1211-6.PMID: 12087021 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia.

Diabetes Atorvastin Lipid Intervention (DALI) Study Group.

Diabetes Care. 2001 Aug;24(8):1335-41.PMID: 11473066 [PubMed - indexed for MEDLINE]Related articlesFree article

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus.

Tan KC, Chow WS, Tam SC, Ai VH, Lam CH, Lam KS.

J Clin Endocrinol Metab. 2002 Feb;87(2):563-8.PMID: 11836286 [PubMed - indexed for MEDLINE]Related articlesFree article

The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes.

Economides PA, Caselli A, Tiani E, Khaodhiar L, Horton ES, Veves A.

J Clin Endocrinol Metab. 2004 Feb;89(2):740-7.PMID: 14764790 [PubMed - indexed for MEDLINE]Related articlesFree article

Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes.

van Etten RW, de Koning EJ, Honing ML, Stroes ES, Gaillard CA, Rabelink TJ.

Arterioscler Thromb Vasc Biol. 2002 May 1;22(5):799-804.PMID: 12006393 [PubMed - indexed for MEDLINE]Related articlesFree article

Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.

Dogra GK, Watts GF, Chan DC, Stanton K.

Diabet Med. 2005 Mar;22(3):239-42.PMID: 15717868 [PubMed - indexed for MEDLINE]Related articles

Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.

Balletshofer BM, Goebbel S, Rittig K, Enderle M, Schmölzer I, Wascher TC, Ferenc Pap A, Westermeier T, Petzinna D, Matthaei S, Häring HU.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):324-30.PMID: 15977099 [PubMed - indexed for MEDLINE]Related articles

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.

Colhoun HM, Thomason MJ, Mackness MI, Maton SM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Fuller JH; Collaborative AtoRvastatin Diabetes Study (CARDS).

Diabet Med. 2002 Mar;19(3):201-11.PMID: 11918622 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein.

Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, Creager MA.

Circ Res. 2004 Jul 23;95(2):217-23. Epub 2004 Jun 3.PMID: 15178637 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study.

Usharani P, Mateen AA, Naidu MU, Raju YS, Chandra N.

Drugs R D. 2008;9(4):243-50.PMID: 18588355 [PubMed - indexed for MEDLINE]Related articles

The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.

Kuryata OV, Yegorova YV.

Kardiol Pol. 2006 Jan;64(1):44-8; discussion 49-50. English, Polish. PMID: 16444629 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.

Alber HF, Frick M, Süssenbacher A, Dörler J, Dichtl W, Stocker EM, Pachinger O, Weidinger F.

Wien Med Wochenschr. 2007 Feb;157(3-4):73-8.PMID: 17340064 [PubMed - indexed for MEDLINE]Related articles

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH; CARDS investigators.

Lancet. 2004 Aug 21-27;364(9435):685-96.PMID: 15325833 [PubMed - indexed for MEDLINE]Related articles

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

Caballero AE, Saouaf R, Lim SC, Hamdy O, Abou-Elenin K, O'Connor C, Logerfo FW, Horton ES, Veves A.

Metabolism. 2003 Feb;52(2):173-80.PMID: 12601628 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study.

Mullen MJ, Wright D, Donald AE, Thorne S, Thomson H, Deanfield JE.

J Am Coll Cardiol. 2000 Aug;36(2):410-6.PMID: 10933350 [PubMed - indexed for MEDLINE]Related articles

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).

Hitman GA, Colhoun H, Newman C, Szarek M, Betteridge DJ, Durrington PN, Fuller J, Livingstone S, Neil HA; CARDS Investigators.

Diabet Med. 2007 Dec;24(12):1313-21. Epub 2007 Sep 26.PMID: 17894827 [PubMed - indexed for MEDLINE]Related articles

Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level.

Tantikosoom W, Thinkhamrop B, Kiatchusakul S, Jarernsiripornkul N, Srinakarin J, Ojongpian S.

J Med Assoc Thai. 2005 Mar;88(3):399-406.PMID: 15962651 [PubMed - indexed for MEDLINE]Related articles

Short-term oral folic acid supplementation enhances endothelial function in patients with type 2 diabetes.

Mangoni AA, Sherwood RA, Asonganyi B, Swift CG, Thomas S, Jackson SH.

Am J Hypertens. 2005 Feb;18(2 Pt 1):220-6.PMID: 15752950 [PubMed - indexed for MEDLINE]Related articles

A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD.

Dogra G, Irish A, Chan D, Watts G.

Am J Kidney Dis. 2007 Jun;49(6):776-85.PMID: 17533020 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study.

Dalla Nora E, Passaro A, Zamboni PF, Calzoni F, Fellin R, Solini A.

J Endocrinol Invest. 2003 Jan;26(1):73-8.PMID: 12602538 [PubMed - indexed for MEDLINE]Related articles